A detailed history of Nuveen Asset Management, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 309,878 shares of MDXG stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
309,878
Previous 305,664 1.38%
Holding current value
$1.81 Million
Previous $2.35 Million 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$6.16 - $8.08 $25,958 - $34,049
4,214 Added 1.38%
309,878 $2.15 Million
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $15,675 - $25,135
2,750 Added 0.91%
305,664 $2.68 Million
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $29,203 - $37,527
4,599 Added 1.54%
302,914 $2.21 Million
Q1 2023

May 15, 2023

SELL
$2.97 - $4.81 $98,829 - $160,057
-33,276 Reduced 10.04%
298,315 $1.02 Million
Q4 2022

Feb 14, 2023

SELL
$2.63 - $3.45 $149,802 - $196,508
-56,959 Reduced 14.66%
331,591 $922,000
Q3 2022

Nov 14, 2022

SELL
$2.71 - $4.22 $29,807 - $46,415
-10,999 Reduced 2.75%
388,550 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$3.17 - $5.0 $1.43 Million - $2.26 Million
-451,537 Reduced 53.05%
399,549 $1.39 Million
Q1 2022

May 16, 2022

BUY
$4.27 - $6.27 $767,681 - $1.13 Million
179,785 Added 26.78%
851,086 $4.03 Million
Q4 2021

Feb 14, 2022

SELL
$5.7 - $8.48 $192,466 - $286,335
-33,766 Reduced 4.79%
671,301 $4.35 Million
Q3 2021

Nov 12, 2021

BUY
$5.52 - $15.83 $106,668 - $305,898
19,324 Added 2.82%
705,067 $10.9 Million
Q2 2021

Aug 16, 2021

BUY
$9.02 - $12.72 $6.19 Million - $8.72 Million
685,743 New
685,743 $8.58 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $662M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.